ARCHIVES

Immunotherapy Demonstrates Disease Control in Phase II Study

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

Accelerated Approval In Oncology Shaves A Year Off Development Time, FDA Data Show

October 30, 2009

NIH Cancer Nurse Turnover Down to 10%

July 24, 1987

NCI Director Klausner Resigns To Head Institute Begun By AOL Chairman Case.

September 14, 2001

Doctor’s Allegation Of Drug Safety Problem Starts Controversy With Manufacturer

May 5, 1995

Clearinghouse Subgroup asks For Tests On Three Chemicals

October 7, 1977

Four DCCP Contracts Costing $9 Million Approved By Board for Recompetition

June 10, 1983